194 related articles for article (PubMed ID: 26567289)
1. TLR7 and TLR9 ligands regulate antigen presentation by macrophages.
Celhar T; Pereira-Lopes S; Thornhill SI; Lee HY; Dhillon MK; Poidinger M; Connolly JE; Lim LH; Biswas SK; Fairhurst AM
Int Immunol; 2016 May; 28(5):223-32. PubMed ID: 26567289
[TBL] [Abstract][Full Text] [Related]
2. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
[TBL] [Abstract][Full Text] [Related]
3. TLR9 and TLR7/8 activation induces formation of keratic precipitates and giant macrophages in the mouse cornea.
Chinnery HR; Leong CM; Chen W; Forrester JV; McMenamin PG
J Leukoc Biol; 2015 Jan; 97(1):103-10. PubMed ID: 25416814
[TBL] [Abstract][Full Text] [Related]
4. Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation.
Derkow K; Krüger C; Dembny P; Lehnardt S
PLoS One; 2015; 10(8):e0135898. PubMed ID: 26288016
[TBL] [Abstract][Full Text] [Related]
5. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29.
Sirén J; Pirhonen J; Julkunen I; Matikainen S
J Immunol; 2005 Feb; 174(4):1932-7. PubMed ID: 15699120
[TBL] [Abstract][Full Text] [Related]
6. TLR9-Activating CpG-B ODN but Not TLR7 Agonists Triggers Antibody Formation to Factor IX in Muscle Gene Transfer.
Butterfield JSS; Biswas M; Shirley JL; Kumar SRP; Sherman A; Terhorst C; Ling C; Herzog RW
Hum Gene Ther Methods; 2019 Jun; 30(3):81-92. PubMed ID: 31140323
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.
Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P
Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 4, Toll-like receptor 7 and Toll-like receptor 9 agonists enhance immune responses against blood-stage Plasmodium chabaudi infection in BALB/c mice.
Gao W; Sun X; Li D; Sun L; He Y; Wei H; Jin F; Cao Y
Int Immunopharmacol; 2020 Dec; 89(Pt B):107096. PubMed ID: 33091818
[TBL] [Abstract][Full Text] [Related]
9. The early induction of suppressor of cytokine signaling 1 and the downregulation of toll-like receptors 7 and 9 induce tolerance in costimulated macrophages.
Lee HJ; Kim KC; Han JA; Choi SS; Jung YJ
Mol Cells; 2015 Jan; 38(1):26-32. PubMed ID: 25518931
[TBL] [Abstract][Full Text] [Related]
10. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia.
Butchi NB; Du M; Peterson KE
Glia; 2010 Apr; 58(6):650-64. PubMed ID: 19998480
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 7 and 9 defects in common variable immunodeficiency.
Yu JE; Knight AK; Radigan L; Marron TU; Zhang L; Sanchez-Ramón S; Cunningham-Rundles C
J Allergy Clin Immunol; 2009 Aug; 124(2):349-56, 356.e1-3. PubMed ID: 19592080
[TBL] [Abstract][Full Text] [Related]
12. Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation.
Jackson SW; Scharping NE; Kolhatkar NS; Khim S; Schwartz MA; Li QZ; Hudkins KL; Alpers CE; Liggitt D; Rawlings DJ
J Immunol; 2014 May; 192(10):4525-32. PubMed ID: 24711620
[TBL] [Abstract][Full Text] [Related]
13. TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity.
Johnson TR; Rao S; Seder RA; Chen M; Graham BS
Vaccine; 2009 May; 27(23):3045-52. PubMed ID: 19428918
[TBL] [Abstract][Full Text] [Related]
14. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors.
Pinhal-Enfield G; Ramanathan M; Hasko G; Vogel SN; Salzman AL; Boons GJ; Leibovich SJ
Am J Pathol; 2003 Aug; 163(2):711-21. PubMed ID: 12875990
[TBL] [Abstract][Full Text] [Related]
15. Guanosine and its modified derivatives are endogenous ligands for TLR7.
Shibata T; Ohto U; Nomura S; Kibata K; Motoi Y; Zhang Y; Murakami Y; Fukui R; Ishimoto T; Sano S; Ito T; Shimizu T; Miyake K
Int Immunol; 2016 May; 28(5):211-22. PubMed ID: 26489884
[TBL] [Abstract][Full Text] [Related]
16. Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing.
Fukui R; Saitoh S; Matsumoto F; Kozuka-Hata H; Oyama M; Tabeta K; Beutler B; Miyake K
J Exp Med; 2009 Jun; 206(6):1339-50. PubMed ID: 19451267
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 8 deletion accelerates autoimmunity in a mouse model of lupus through a Toll-like receptor 7-dependent mechanism.
Tran NL; Manzin-Lorenzi C; Santiago-Raber ML
Immunology; 2015 May; 145(1):60-70. PubMed ID: 25424423
[TBL] [Abstract][Full Text] [Related]
18. Activation of NF-κB via endosomal Toll-like receptor 7 (TLR7) or TLR9 suppresses murine herpesvirus 68 reactivation.
Haas F; Yamauchi K; Murat M; Bernasconi M; Yamanaka N; Speck RF; Nadal D
J Virol; 2014 Sep; 88(17):10002-12. PubMed ID: 24942583
[TBL] [Abstract][Full Text] [Related]
19. TLR7 Agonist Suppresses Group 2 Innate Lymphoid Cell-mediated Inflammation via IL-27-Producing Interstitial Macrophages.
Okuzumi S; Miyata J; Kabata H; Mochimaru T; Kagawa S; Masaki K; Irie M; Morita H; Fukunaga K
Am J Respir Cell Mol Biol; 2021 Sep; 65(3):309-318. PubMed ID: 34003734
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 7 mediates early innate immune responses to malaria.
Baccarella A; Fontana MF; Chen EC; Kim CC
Infect Immun; 2013 Dec; 81(12):4431-42. PubMed ID: 24042114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]